MASHAM & KIRKBY MALZEARD SURGERY — All Prescriptions & Medications — Page 4
Practice Code: B82030 | RIPON, HG4 4DZ
Showing results 151-200 of 563
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 147 | 3,534 | £8.8K | +273.6% ▲ | |
| Cyanocobalamin | 146 | 8,378 | £999 | -58.6% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 144 | 21.6K | £1.2K | -4.7% ▼ |
| Insulin degludec | 143 | 653 | £8.1K | +30.1% ▲ |
| Bumetanide | 142 | 8,323 | £865 | -47.9% ▼ |
| Lymecycline | 142 | 5,684 | £696 | +18.1% ▲ |
| Tadalafil | 142 | 2,932 | £457 | -16.5% ▼ |
| Eplerenone | 141 | 4,083 | £525 | -46.8% ▼ |
| 141 | 141 | £6.0K | -54.6% ▼ | |
| Hydroxychloroquine sulfate | 140 | 4,076 | £197 | -27.7% ▼ |
| 139 | 1,275 | £417 | -44.3% ▼ | |
| Insulin glargine | 137 | 681 | £5.1K | -51.7% ▼ |
| Ferrous sulfate | 137 | 5,357 | £194 | -73.4% ▼ |
| Docusate sodium | 136 | 11.5K | £798 | -63.3% ▼ |
| Clobetasol propionate | 135 | 9,240 | £685 | -1.1% vs avg |
| Pantoprazole | 133 | 5,040 | £245 | -51.6% ▼ |
| Estradiol with progestogen | 133 | 4,320 | £3.1K | -61.0% ▼ |
| Calcipotriol | 133 | 9,360 | £5.3K | -21.9% ▼ |
| Lactulose | 132 | 85.9K | £755 | -59.9% ▼ |
| Nortriptyline | 131 | 7,029 | £253 | -10.0% ▼ |
| Timolol | 129 | 3,040 | £986 | +45.9% ▲ |
| Methenamine hippurate | 127 | 7,756 | £1.8K | +39.6% ▲ |
| 127 | 128 | £655 | -46.2% ▼ | |
| Mesalazine (Systemic) | 125 | 13.5K | £6.5K | -47.8% ▼ |
| Verapamil hydrochloride | 123 | 6,860 | £751 | +35.6% ▲ |
| Risedronate sodium | 122 | 508 | £145 | +0.6% vs avg |
| Other multivitamin preparations | 122 | 3,988 | £1.2K | -29.4% ▼ |
| Trazodone hydrochloride | 121 | 6,422 | £171 | -40.8% ▼ |
| Betahistine hydrochloride | 119 | 11.1K | £381 | -50.2% ▼ |
| Terbinafine hydrochloride | 119 | 4,235 | £1.6K | +92.5% ▲ |
| 119 | 38.4K | £723 | -54.9% ▼ | |
| Acetylcysteine | 118 | 3,550 | £596 | +65.1% ▲ |
| Celecoxib | 117 | 7,362 | £442 | +77.2% ▲ |
| Sodium cromoglicate | 117 | 1,741 | £441 | +25.9% ▲ |
| Oxybutynin | 115 | 6,542 | £1.2K | -39.6% ▼ |
| Zolmitriptan | 110 | 960 | £3.0K | +69.4% ▲ |
| 109 | 1,547 | £1.2K | +6.7% ▲ | |
| Ranolazine | 108 | 5,523 | £1.1K | -36.4% ▼ |
| Hydrocortisone | 102 | 2,280 | £495 | +34.3% ▲ |
| 102 | 22.5K | £1.1K | +0.4% vs avg | |
| Anastrozole | 100 | 2,800 | £109 | +9.8% ▲ |
| 99 | 6,925 | £862 | +100.3% ▲ | |
| Hydrocortisone | 96 | 5,706 | £904 | +13.7% ▲ |
| Sulfasalazine | 95 | 10.2K | £3.2K | -27.0% ▼ |
| Nicorandil | 95 | 7,320 | £993 | -34.0% ▼ |
| Sodium valproate | 94 | 9,780 | £1.3K | -70.4% ▼ |
| Cyclizine hydrochloride | 93 | 5,220 | £188 | -42.3% ▼ |
| Prochlorperazine maleate | 93 | 2,522 | £247 | -54.0% ▼ |
| Cefalexin | 93 | 2,491 | £220 | -20.0% ▼ |
| Clobetasone butyrate | 91 | 3,720 | £436 | -55.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.